DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
about
Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunityDNA vaccines: developing new strategies against cancer.Genetic immunization with CDR3-based fusion vaccine confers protection and long-term tumor-free survival in a mouse model of lymphomaReversal of papilloma growth in rabbits therapeutically vaccinated against E6 with naked DNA and/or vesicular stomatitis virus vectors.DNA vaccines: ready for prime time?Mechanisms of immunization against cancer using chimeric antigens.DNA vaccines to attack cancerAntiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococciAdjuvants in vaccines and for immunisation: current trends.Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression.Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes.Tumor endothelial marker 1-specific DNA vaccination targets tumor vasculature.The rationale of vectored gene-fusion vaccines against cancer: evolving strategies and latest evidence.Targeting tumor vasculature: expanding the potential of DNA cancer vaccines.Enhancement of DNA vaccine efficacy by targeting the xenogeneic human chorionic gonadotropin, survivin and vascular endothelial growth factor receptor 2 combined tumor antigen to the major histocompatibility complex class II pathway.Dendritic and tumor cell fusions transduced with adenovirus encoding CD40L eradicate B-cell lymphoma and induce a Th17-type response.Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7.Phase I clinical trial of idiotypic DNA vaccine administered as a complex with polyethylenimine to patients with B-cell lymphoma.Comparison of recombinant adenovirus and synthetic peptide for DC-based melanoma vaccination.DNA fusion gene vaccination mobilizes effective anti-leukemic cytotoxic T lymphocytes from a tolerized repertoire.Suppression of breast tumor growth by DNA vaccination against phosphatase of regenerating liver 3.The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen.'Survival gene' Bcl-xl potentiates DNA-raised antitumor immunity.Linked CD4 T Cell Help: Broadening Immune Attack Against Cancer by Vaccination.Graft-versus-host and graft-versus-leukemia reactions: a summary of the Seventh International Symposium held in Garmisch-Partenkirchen, Germany, February 22nd-25th, 2006, Tolerance and Immunity, an update on lymphoid malignancies.Generating DNA sequences encoding tandem peptide repeats suitable for expression and immunological application.Plastid expression of a double-pentameric vaccine candidate containing human papillomavirus-16 L1 antigen fused with LTB as adjuvant: transplastomic plants show pleiotropic phenotypes
P2860
Q33327757-B3A8757D-1D84-42AD-B902-C025CC9731C8Q33756622-CE805282-4C2E-49AF-AB16-9C03244D89BEQ33814247-83CCF087-CFB6-477F-BE5B-FE31ED259AB8Q33940220-FC223523-3D78-4AAA-BA8E-443561A0C3DEQ34824179-5D62D60B-6C97-4F20-B61C-0A9AA4295D9EQ35442846-3DE99443-4A19-47FF-8DE6-95EB993BA05FQ35855143-145E5D57-B57E-426D-8D9F-49007974BAC0Q36227917-6260ABE3-3B49-46E3-8BD5-BCD8D5247B9CQ36960502-4AD1B835-6778-4EF6-BB6D-E3220B08909DQ36984725-B6433B0F-7F71-422D-AF45-A034EDF1F3B1Q37671730-4B3E7CCE-11A6-408B-8F71-C103EBBCD3F4Q37679962-8F94A384-FC16-47C9-AABE-22070B8CB647Q38206518-B97EF735-E6E0-4C03-A083-847E0F6DCE55Q38565385-5ECAEBBD-7E9F-4943-97E3-FC5C54315ED6Q39637966-9293559D-0632-4890-B6D1-595DB45C45D2Q39763286-F09672D4-946F-4860-AB14-154FCC12BFA3Q39796733-E6D9B586-16DB-4727-ABBC-68FC8894DDFCQ40302619-C99EF56B-1126-4226-A945-9024F19A92CEQ40390484-BC85149C-4B67-48EF-9057-E594BCF16E72Q42949404-7D4DFE1D-E3C0-4226-9873-6BA9B3846137Q43522873-4D05DE3D-E688-42E8-A059-F2AC83538C94Q45355231-AB18FBB7-17F4-4420-BD1A-7C15D9D364A7Q45885513-DC8C6DD2-A7BC-4FFD-AF18-17ECB8833C46Q49013708-7F521D27-80D5-43FF-88FA-3E15681C39FAQ53249666-8CE7519E-62AE-43DF-830C-2D58059103F8Q54300399-13F31AA9-CC70-41DC-B1FA-F32EB60B680BQ57247534-83476DEF-0D25-40CA-828D-7BC942858192
P2860
DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
@ast
DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
@en
type
label
DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
@ast
DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
@en
prefLabel
DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
@ast
DNA fusion gene vaccines against cancer: from the laboratory to the clinic.
@en
P2093
P2860
P1476
DNA fusion gene vaccines against cancer: from the laboratory to the clinic
@en
P2093
Jason Rice
Stephen M Thirdborough
P2860
P304
P356
10.1111/J.0105-2896.2004.00145.X
P577
2004-06-01T00:00:00Z